4/1
07:00 am
tnxp
Tonix Pharmaceuticals Launches TONIX ONE™, a Fully-Integrated Digital Platform Designed to Help Patients Better Understand and Manage Their Migraine Condition
Medium
Report
Tonix Pharmaceuticals Launches TONIX ONE™, a Fully-Integrated Digital Platform Designed to Help Patients Better Understand and Manage Their Migraine Condition
3/31
07:41 am
tnxp
Tonix's Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year [Yahoo! Finance]
Medium
Report
Tonix's Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year [Yahoo! Finance]
3/27
07:00 am
tnxp
Tonix Pharmaceuticals Announces Presentation at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting
Medium
Report
Tonix Pharmaceuticals Announces Presentation at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting
3/24
08:08 am
tnxp
Tonix Pharmaceuticals Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for TNX-102 SL for the Management of Fibromyalgia [Yahoo! Finance]
High
Report
Tonix Pharmaceuticals Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for TNX-102 SL for the Management of Fibromyalgia [Yahoo! Finance]
3/24
08:00 am
tnxp
Tonix Pharmaceuticals Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for TNX-102 SL for the Management of Fibromyalgia
High
Report
Tonix Pharmaceuticals Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for TNX-102 SL for the Management of Fibromyalgia
3/20
12:32 pm
tnxp
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) had its "outperform" rating re-affirmed by analysts at Noble Financial. They now have a $70.00 price target on the stock.
Medium
Report
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) had its "outperform" rating re-affirmed by analysts at Noble Financial. They now have a $70.00 price target on the stock.
3/18
04:59 pm
tnxp
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights [Yahoo! Finance]
High
Report
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights [Yahoo! Finance]
3/18
04:30 pm
tnxp
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
High
Report
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
3/13
07:00 am
tnxp
Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring 2025
Low
Report
Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring 2025
3/11
07:00 am
tnxp
Tonix Pharmaceuticals to Present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13th
Medium
Report
Tonix Pharmaceuticals to Present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13th
3/10
08:07 am
tnxp
Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Company's Single-Dose Mpox and Smallpox Vaccine Candidate [Yahoo! Finance]
Low
Report
Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Company's Single-Dose Mpox and Smallpox Vaccine Candidate [Yahoo! Finance]
3/10
08:00 am
tnxp
Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Company’s Single-Dose Mpox and Smallpox Vaccine Candidate
Low
Report
Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Company’s Single-Dose Mpox and Smallpox Vaccine Candidate
3/5
07:00 am
tnxp
Tonix Pharmaceuticals to Present at the 2025 Virtual Investor Summit
High
Report
Tonix Pharmaceuticals to Present at the 2025 Virtual Investor Summit
3/4
07:07 am
tnxp
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at 7th International Congress on Controversies in Fibromyalgia [Yahoo! Finance]
Medium
Report
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at 7th International Congress on Controversies in Fibromyalgia [Yahoo! Finance]
3/4
07:00 am
tnxp
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at 7th International Congress on Controversies in Fibromyalgia
Medium
Report
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at 7th International Congress on Controversies in Fibromyalgia
2/10
01:15 am
tnxp
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
2/7
12:19 pm
tnxp
Tonix Pharmaceuticals reports positive topline trial outcomes of TNX-1500 [Yahoo! Finance]
Medium
Report
Tonix Pharmaceuticals reports positive topline trial outcomes of TNX-1500 [Yahoo! Finance]
2/7
09:09 am
tnxp
Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash [Yahoo! Finance]
High
Report
Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash [Yahoo! Finance]
2/7
09:01 am
tnxp
Tonix Pharma says it had about $98.8M in cash and cash equivalents as of Dec 31, 2024 [Seeking Alpha]
Medium
Report
Tonix Pharma says it had about $98.8M in cash and cash equivalents as of Dec 31, 2024 [Seeking Alpha]
2/7
08:30 am
tnxp
Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash
Medium
Report
Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash
2/6
10:13 am
tnxp
Tonix Pharmaceuticals Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Autoimmune Diseases [Yahoo! Finance]
High
Report
Tonix Pharmaceuticals Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Autoimmune Diseases [Yahoo! Finance]
2/6
08:00 am
tnxp
Tonix Pharmaceuticals Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Autoimmune Diseases
High
Report
Tonix Pharmaceuticals Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Autoimmune Diseases
2/4
07:50 am
tnxp
Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer [Yahoo! Finance]
High
Report
Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer [Yahoo! Finance]
2/4
07:47 am
tnxp
Tonix Pharmaceuticals promotes Fogarty to CTO [Seeking Alpha]
High
Report
Tonix Pharmaceuticals promotes Fogarty to CTO [Seeking Alpha]
2/4
07:00 am
tnxp
Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer
Medium
Report
Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer